What is Seqster?
Seqster operates as a Software-as-a-Service (SaaS) based healthcare technology company. Its core offering is to enable organizations to achieve efficient healthcare delivery through the comprehensive aggregation of medical records (EHR), individual genomic profiles (DNA), and personal health device data. Through person-centric interoperability, Seqster empowers users to construct their own longitudinal health data profiles, integrating information from all their US-based healthcare data sources. The company's innovative platform serves a diverse range of healthcare enterprises, including pharmaceutical companies, payers, life insurance providers, and healthcare systems.
How much funding has Seqster raised?
Seqster has raised a total of $12M across 1 funding round:
Series A
$12M
Series A (2021): $12M with participation from Takeda Digital Ventures, OmniHealth Holdings, and Ann Wojcicki
What's next for Seqster?
This substantial enterprise-level funding, particularly the recent strategic investment, positions Seqster for accelerated scaling and market expansion. The capital infusion is expected to fuel further development of its interoperability solutions and enhance its data aggregation capabilities. As Seqster continues to build out its platform, it is likely to deepen its partnerships within the healthcare ecosystem, aiming to become a central hub for unified health data. The company's focus on person-centric data management signals a strategic move towards empowering individuals and transforming how healthcare data is accessed and utilized across various stakeholders.
See full Seqster company page
